DE FRANCESCO, ERNESTINA MARIANNA
 Distribuzione geografica
Continente #
EU - Europa 377
AS - Asia 214
NA - Nord America 151
AF - Africa 1
SA - Sud America 1
Totale 744
Nazione #
IE - Irlanda 337
US - Stati Uniti d'America 150
HK - Hong Kong 124
SG - Singapore 86
DE - Germania 20
FI - Finlandia 9
LT - Lituania 3
FR - Francia 2
JP - Giappone 2
KR - Corea 2
RU - Federazione Russa 2
BR - Brasile 1
EG - Egitto 1
HR - Croazia 1
IT - Italia 1
LV - Lettonia 1
MX - Messico 1
NL - Olanda 1
Totale 744
Città #
Dublin 327
Hong Kong 124
Boardman 85
Singapore 57
Los Angeles 26
Munich 19
Helsinki 9
Ashburn 5
Chicago 4
Kurosunadai 2
Seoul 2
West Jordan 2
Cairo 1
Milan 1
New York 1
Newark 1
Nuremberg 1
Paris 1
Puebla 1
Riga 1
San Diego 1
São Paulo 1
Zagreb 1
Totale 673
Nome #
Activation of the s100a7/rage pathway by igf-1 contributes to angiogenesis in breast cancer 22
Recent Advances on the Role of G Protein-Coupled Receptors in Hypoxia-Mediated Signaling 22
Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells 21
Cross-talk between GPER and growth factor signaling 20
Estrogen receptor variant ERα46 and insulin receptor drive in primary breast cancer cells growth effects and interleukin 11 induction prompting the motility of cancer‐associated fibroblasts 20
Editorial: A year in review: discussions in molecular and structural endocrinology 20
A calixpyrrole derivative acts as an antagonist to GPER, a G-protein coupled receptor: Mechanisms and models 20
The AGEs/RAGE Transduction Signaling Prompts IL-8/CXCR1/2-Mediated Interaction between Cancer-Associated Fibroblasts (CAFs) and Breast Cancer Cells 19
COVID-19 and Diabetes: The Importance of Controlling RAGE 19
A Bodipy as a luminescent probe for detection of the G protein estrogen receptor (GPER) 19
Cancer stem cells (CSCs): Metabolic strategies for their identification and eradication 19
The G protein-coupled receptor 30 is up-regulated by hypoxia-inducible factor-1α (HIF-1α) in breast cancer cells and cardiomyocytes 18
The G protein estrogen receptor (GPER) is regulated by endothelin-1 mediated signaling in cancer cells 18
G Protein-Coupled Receptors at the Crossroad between Physiologic and Pathologic Angiogenesis: Old Paradigms and Emerging Concepts 18
Focal Adhesion Kinase (FAK)-Hippo/YAP transduction signaling mediates the stimulatory effects exerted by S100A8/A9-RAGE system in triple-negative breast cancer (TNBC) 17
Mitochondrial Fission Factor (MFF) Inhibits Mitochondrial Metabolism and Reduces Breast Cancer Stem Cell (CSC) Activity 17
NADH autofluorescence, a new metabolic biomarker for cancer stem cells: Identification of Vitamin C and CAPE as natural products targeting "stemness" 17
RAGE inhibition blunts insulin-induced oncogenic signals in breast cancer 17
Palmitate-Induced Cardiac Lipotoxicity Is Relieved by the Redox-Active Motif of SELENOT through Improving Mitochondrial Function and Regulating Metabolic State 17
The G Protein-Coupled Estrogen Receptor (GPER) Expression Correlates with Pro-Metastatic Pathways in ER-Negative Breast Cancer: A Bioinformatics Analysis 17
Insulin/IGF axis and the Receptor for Advanced Glycation End Products: role in meta-inflammation and potential in cancer therapy 16
GPER, IGF-IR, and EGFR transduction signaling are involved in stimulatory effects of zinc in breast cancer cells and cancer-associated fibroblasts 16
Crosstalk between notch, HIF-1α and GPER in breast cancer EMT 16
Bisphenol A induces gene expression changes and proliferative effects through GPER in breast cancer cells and cancer-associated fibroblasts 16
Estrogen Receptors and Chronic Venous Disease 16
A mitochondrial based oncology platform for targeting cancer stem cells (CSCs): MITO-ONC-RX 14
The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs) 14
Stimulatory actions of IGF-I are mediated by IGF-IR cross-talk with GPER and DDR1 in mesothelioma and lung cancer cells 13
The cholesterol metabolite 25-Hydroxycholesterol activates estrogen receptor α-Mediated signaling in cancer cells and in cardiomyocytes 13
Copper activates HIF-1α/GPER/VEGF signalling in cancer cells 13
GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells 12
Multifactorial regulation of GPER expression in cancer cells and cardiomyocytes 12
Protective role of GPER Agonist G-1 on cardiotoxicity induced by doxorubicin 12
Cancer associated fibroblasts: role in breast cancer and potential as therapeutic targets 12
HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs) 11
Targeting hypoxic cancer stem cells (CSCs) with Doxycycline: Implications for optimizing anti-angiogenic therapy 11
Dodecyl-TPP Targets Mitochondria and Potently Eradicates Cancer Stem Cells (CSCs): Synergy With FDA-Approved Drugs and Natural Compounds (Vitamin C and Berberine) 11
Ddr1 affects metabolic reprogramming in breast cancer cells by cross-talking to the insulin/igf system 11
IGF2: A Role in Metastasis and Tumor Evasion from Immune Surveillance? 10
GPER is involved in the stimulatory effects of aldosterone in breast cancer cells and breast tumor-derived endothelial cells 10
Triple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progress 10
Mitochondrial Determinants of Anti-Cancer Drug-Induced Cardiotoxicity 9
Two novel GPER agonists induce gene expression changes and growth effects in cancer cells 9
Metformin counteracts stimulatory effects induced by insulin in primary breast cancer cells 9
Editorial: Early diagnoses and treatments of uncommon breast cancers 9
The Ephrin tyrosine kinase a3 (EphA3) is a novel mediator of RAGE-prompted motility of breast cancer cells 8
IGF2: A Role in Metastasis and Tumor Evasion from Immune Surveillance? 8
Crucial role of phospholamban phosphorylation and s-nitrosylation in the negative lusitropism induced by 17β-estradiol in the male rat heart 8
The G Protein Estrogen Receptor (GPER) is involved in the resistance to the CDK4/6 inhibitor palbociclib in breast cancer 7
GPER mediates activation of HIF1α/VEGF signaling by estrogens 7
Notch1 mediates preconditioning protection induced by GPER in normotensive and hypertensive female rat hearts 7
IFN-I signaling in cancer: the connection with dysregulated Insulin/IGF axis 7
Microenvironmental Determinants of Breast Cancer Metastasis: Focus on the Crucial Interplay Between Estrogen and Insulin/Insulin-Like Growth Factor Signaling 6
Niacin activates the G protein estrogen receptor (GPER)-mediated signalling 6
SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer 6
Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer 6
Cancer-associated fibroblasts (CAFs) gene signatures predict outcomes in breast and prostate tumor patients 6
Harnessing sample preparation for RNA-sequencing toward a reliable bioinformatics analysis 5
GPER signalling in both cancer-associated fibroblasts and breast cancer cells mediates a feedforward IL1β/IL1R1 response 5
Vitamin C and Doxycycline: A synthetic lethal combination therapy targeting metabolic flexibility in cancer stem cells (CSCs) 5
SLC37A1 Gene expression is up-regulated by epidermal growth factor in breast cancer cells 5
GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment 5
GPER mediates cardiotropic effects in Spontaneously Hypertensive Rat hearts 5
Pregnancy augments G protein estrogen receptor (GPER) induced vasodilation in rat uterine arteries via the nitric oxide - cGMP signaling pathway 5
GPER deletion triggers inhibitory effects in triple negative breast cancer (TNBC) cells through the JNK/c-Jun/p53/Noxa transduction pathway 5
The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs) 4
null 2
null 1
Totale 811
Categoria #
all - tutte 7.472
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.472


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024438 0 0 0 0 0 0 0 63 75 76 159 65
2024/2025373 91 74 94 35 79 0 0 0 0 0 0 0
Totale 811